Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Khiron Life Sciences Corp KHRNF


Primary Symbol: V.KHRN.H Alternate Symbol(s):  V.KHRN.WT.H | KHRWF

Khiron Life Sciences Corp. is a Canada-based medical cannabis company with core operations in Latin America. The Company has its wholly owned medical health clinics and telemedicine platforms. The Company has two product lines: Medical Cannabis Products and Health Services. It sells branded medical cannabis products to patients with medical conditions. Under the Medical Cannabis Products line... see more

TSXV:KHRN.H - Post Discussion

Khiron Life Sciences Corp > I'm hoping this dog will run soon!
View:
Post by zzstocks70 on Jun 02, 2021 10:59am

I'm hoping this dog will run soon!

I obviously picked the biggest dog of the weed space.... hopefully these guys get this thing moving. Imo glta
Comment by DukeofEarl on Jun 03, 2021 1:00pm
Not really a dog IMHO, it was just caught up in the weed pump a bit early. Revenues are growing quite quickly and insurance coverage in Colombia is only just beginning to take hold.... Cannabis oil is 60% cheaper than opiodes in Colombia to treat patients with chronic pain. Insurance companies will stampede towards this medicine in short order.
Comment by Benedictus on Jun 05, 2021 11:26am
The race is on between the cash burn and revenue build and unfortunately the cash burn is ahead by a country mile. The execution is definitely coming together with script issuance growth, good customer retention, insurance coverage and adding more sales in Germany and the UK, BUT the company does not have 2 full quarters of cash left and they cannot close the gap. They need funds and will have to ...more  
Comment by Benedictus on Jul 06, 2021 11:17am
No surprise with today's announcement. The terms are very disappointing, virtually identical to the terms of the last placement announced almost 7 months ago.  I like this company a lot but I do not like the burgeoning share structure, the rate of cash burn and the ongoing shareholder unfriendly terms of these placements. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities